Refine
Year of publication
Document Type
- Article (14)
- Conference Proceeding (2)
- Book (1)
- Doctoral Thesis (1)
- Report (1)
Has Fulltext
- yes (19)
Is part of the Bibliography
- no (19)
Keywords
- ALK-rearranged NSCLC (1)
- Ageing (1)
- Alternsforschung (1)
- Cancer (1)
- Cancer genetics (1)
- Cancer genomics (1)
- Chemotherapy (1)
- Chromosomal deletion (1)
- Demography (1)
- Deutsch (1)
- Digestive system (1)
- Digitalization (1)
- Endoscopy (1)
- Evidence-based guidelines (1)
- Fibrotest (1)
- Forschungsbericht (1)
- Frauenpolitik (KPD) (1)
- Genomic instability (1)
- Germanistik (1)
- HCV (1)
- HIV (1)
- Hepatotoxicity (1)
- IgG4-related disease (1)
- Indeterminate biliary stricture (1)
- Intestinal neoplasms (1)
- Kongressbericht (1)
- Lebensqualität (1)
- Literatur (1)
- Liver enzymes (1)
- Lung Cancer (1)
- Medienkompetenz (1)
- Molecular medicine (1)
- Non-small cell lung cancer (1)
- PCR (1)
- Paragraph 218 (StGB) (1)
- Participation (1)
- Politischer Prozeß (1)
- Prognosis (1)
- Psoriasis vulgaris (1)
- ROS1 (1)
- Schwangerschaftsabbruch (1)
- Self-expandable metal stents (1)
- Self-expandable metal stents complications (1)
- Smartphone (1)
- TP53 mutation status (1)
- Techniknutzung (1)
- Technology (1)
- Tetrastigma voinierianum (1)
- Transient elastography (1)
- Treatment (1)
- Tumor obstruction (1)
- aging (1)
- ambulatory assessment (1)
- bile duct stenosis (1)
- biliary stricture (1)
- cART (1)
- co-infection (1)
- context (1)
- deletion 5q (1)
- endoscopic retrograde cholangiopancreatography (1)
- endoscopy (1)
- eosinophilic cholangitis (1)
- experience sampling (1)
- irrigation (1)
- leaf patch clamp pressure (1)
- liana (1)
- liver transplantation (1)
- multidrug resistance (1)
- myelodysplastic syndrome (1)
- primary sclerosing cholangitis (1)
- real-life study (1)
- recurrent cholangitis (1)
- sequential ALK-inhibitor therapy (1)
- short tandem repeats (1)
- short-course antibiotic therapy (1)
- situation (1)
- transfer function (1)
- turgor pressure (1)
- turgor pressure probe (1)
Institute
- Medizin (12)
- Erziehungswissenschaften (3)
- Biochemie und Chemie (1)
Background: 15-20% of all patients initially diagnosed with colorectal cancer develop metastatic disease and surgical resection remains the only potentially curative treatment available. Current 5-year survival following R0-resection of liver metastases is 28-39%, but recurrence eventually occurs in up to 70%. To date, adjuvant chemotherapy has not improved clinical outcomes significantly. The primary objective of the ongoing LICC trial (L-BLP25 In Colorectal Cancer) is to determine whether L-BLP25, an active cancer immunotherapy, extends recurrence-free survival (RFS) time over placebo in colorectal cancer patients following R0/R1 resection of hepatic metastases. L-BLP25 targets MUC1 glycoprotein, which is highly expressed in hepatic metastases from colorectal cancer. In a phase IIB trial, L-BLP25 has shown acceptable tolerability and a trend towards longer survival in patients with stage IIIB locoregional NSCLC.
Methods: This is a multinational, phase II, multicenter, randomized, double-blind, placebo-controlled trial with a sample size of 159 patients from 20 centers in 3 countries. Patients with stage IV colorectal adenocarcinoma limited to liver metastases are included. Following curative-intent complete resection of the primary tumor and of all synchronous/metachronous metastases, eligible patients are randomized 2:1 to receive either L-BLP25 or placebo. Those allocated to L-BLP25 receive a single dose of 300 mg/m2 cyclophosphamide (CP) 3 days before first L-BLP25 dose, then primary treatment with s.c. L-BLP25 930 mug once weekly for 8 weeks, followed by s.c. L-BLP25 930 mug maintenance doses at 6-week (years 1&2) and 12-week (year 3) intervals unless recurrence occurs. In the control arm, CP is replaced by saline solution and L-BLP25 by placebo. Primary endpoint is the comparison of recurrence-free survival (RFS) time between groups. Secondary endpoints are overall survival (OS) time, safety, tolerability, RFS/OS in MUC-1 positive cancers. Exploratory immune response analyses are planned. The primary endpoint will be assessed in Q3 2016. Follow-up will end Q3 2017. Interim analyses are not planned.
Discussion: The design and implementation of such a vaccination study in colorectal cancer is feasible. The study will provide recurrence-free and overall survival rates of groups in an unbiased fashion. Trial Registration EudraCT Number 2011-000218-20
Schwermetall-Untersuchungen entlang der Düte und der Hase zeigen die starke Belastung der Auenböden jeweils unterhalb der Städte Georgsmarienhütte bzw. Osnabrück. In den Böden beider Auen erreichen Blei, Zink und Cadmium beträchtliche, die Bodenwerte der AbfKlärVO (1992) z.T. erheblich überschreitende Werte. In den Böden entlang der Hase tritt zudem Kupfer mit besonders hohen Werten auf. Diese Unterschiede stehen in Zusammenhang mit der Art der jeweiligen Industriestandorte (Eisenhütte bzw. Metaliverarbeitung).
A high-precision pressure probe is described which allows non-invasive online-monitoring of the water relations of intact leaves. Real-time recording of the leaf water status occurred by data transfer to an Internet server. The leaf patch clamp pressure probe measures the attenuated pressure, Pp, of a leaf patch in response to a constant clamp pressure, Pclamp. Pp is sensed by a miniaturized silicone pressure sensor integrated into the device. The magnitude of Pp is dictated by the transfer function of the leaf, Tf, which is a function of leaf patch volume and ultimately of cell turgor pressure, Pc, as shown theoretically. The power function Tf=f(Pc) theoretically derived was experimentally confirmed by concomitant Pp and Pc measurements on intact leaflets of the liana Tetrastigma voinierianum under greenhouse conditions. Simultaneous Pp recordings on leaflets up to 10 m height above ground demonstrated that changes in Tf induced by Pc changes due to changes of microclimate and/or of the irrigation regime were sensitively reflected in corresponding changes of Pp. Analysis of the data show that transpirational water loss during the morning hours was associated with a transient rise in turgor pressure gradients within the leaflets. Subsequent recovery of turgescence during the afternoon was much faster than the preceding transpiration-induced water loss if the plants were well irrigated. Our data show the enormous potential of the leaf patch clamp pressure probe for leaf water studies including unravelling of the hydraulic communication between neighbouring leaves and over long distances within tall plants (trees).
Background: Liver fibrosis in human immunodeficiency virus (HIV)-infected individuals is mostly attributable to co-infection with hepatitis B or C. The impact of other risk factors, including prolonged exposure to combined antiretroviral therapy (cART) is poorly understood. Our aim was to determine the prevalence of liver fibrosis and associated risk factors in HIV-infected individuals based on non-invasive fibrosis assessment using transient elastography (TE) and serum biomarkers (Fibrotest [FT]).
Methods: In 202 consecutive HIV-infected individuals (159 men; mean age 47 ± 9 years; 35 with hepatitis-C-virus [HCV] co-infection), TE and FT were performed. Repeat TE examinations were conducted 1 and 2 years after study inclusion.
Results: Significant liver fibrosis was present in 16% and 29% of patients, respectively, when assessed by TE (≥ 7.1 kPa) and FT (> 0.48). A combination of TE and FT predicted significant fibrosis in 8% of all patients (31% in HIV/HCV co-infected and 3% in HIV mono-infected individuals). Chronic ALT, AST and γ-GT elevation was present in 29%, 20% and 51% of all cART-exposed patients and in 19%, 8% and 45.5% of HIV mono-infected individuals. Overall, factors independently associated with significant fibrosis as assessed by TE (OR, 95% CI) were co-infection with HCV (7.29, 1.95-27.34), chronic AST (6.58, 1.30-33.25) and γ-GT (5.17, 1.56-17.08) elevation and time on dideoxynucleoside therapy (1.01, 1.00-1.02). In 68 HIV mono-infected individuals who had repeat TE examinations, TE values did not differ significantly during a median follow-up time of 24 months (median intra-patient changes at last TE examination relative to baseline: -0.2 kPa, p = 0.20).
Conclusions: Chronic elevation of liver enzymes was observed in up to 45.5% of HIV mono-infected patients on cART. However, only a small subset had significant fibrosis as predicted by TE and FT. There was no evidence for fibrosis progression during follow-up TE examinations.
Eosinophilic cholangitis is a potentially underdiagnosed etiology in indeterminate biliary stricture
(2017)
AIM: To investigate presence and extent of eosinophilic cholangitis (EC) as well as IgG4-related disease in patients with indeterminate biliary stricture (IBS).
METHODS: All patients with diagnosis of sclerosing cholangitis (SC) and histopathological samples such as biopsies or surgical specimens at University Hospital Frankfurt from 2005-2015 were included. Histopathological diagnoses as well as further clinical course were reviewed. Tissue samples of patients without definite diagnosis after complete diagnostic work-up were reviewed regarding presence of eosinophilic infiltration and IgG4 positive plasma cells. Eosinophilic infiltration was as well assessed in a control group of liver transplant donors and patients with primary sclerosing cholangitis.
RESULTS: one hundred and thirty-five patients with SC were included. In 10/135 (13.5%) patients, no potential cause of IBS could be identified after complete diagnostic work-up and further clinical course. After histopathological review, a post-hoc diagnosis of EC was established in three patients resulting in a prevalence of 2.2% (3/135) of all patients with SC as well as 30% (3/10) of patients, where no cause of IBS was identified. 2/3 patients with post-hoc diagnosis of EC underwent surgical resection with suspicion for malignancy. Diagnosis of IgG4-related cholangitis was observed in 7/135 patients (5.1%), whereas 3 cases were discovered in post-hoc analysis. 6/7 cases with IgG4-related cholangitis (85.7%) presented with eosinophilic infiltration in addition to IgG4 positive plasma cells. There was no patient with eosinophilic infiltration in the control group of liver transplant donors (n = 27) and patients with primary sclerosing cholangitis (n = 14).
CONCLUSION: EC is an underdiagnosed benign etiology of SC and IBS, which has to be considered in differential diagnosis of IBS.
Aim: To compare clinical success and complications of uncovered self-expanding metal stents (SEMS) vs covered SEMS (cSEMS) in obstruction of the small bowel.
Methods: Technical success, complications and outcome of endoscopic SEMS or cSEMS placement in tumor related obstruction of the duodenum or jejunum were retrospectively assessed. The primary end points were rates of stent migration and overgrowth. Secondary end points were the effect of concomitant biliary drainage on migration rate and overall survival. The data was analyzed according to the Strengthening the Reporting of Observational Studies in Epidemiology guidelines.
Results: Thirty-two SEMS were implanted in 20 patients. In all patients, endoscopic stent implantation was successful. Stent migration was observed in 9 of 16 cSEMS (56%) in comparison to 0/16 SEMS (0%) implantations (P = 0.002). Stent overgrowth did not significantly differ between the two stent types (SEMS: 3/16, 19%; cSEMS: 2/16, 13%). One cSEMS dislodged and had to be recovered from the jejunum by way of laparotomy. Time until migration between SEMS and cSEMS in patients with and without concomitant biliary stents did not significantly differ (HR = 1.530, 95%CI 0.731-6.306; P = 0.556). The mean follow-up was 57 ± 71 d (range: 1-275 d).
Conclusion: SEMS and cSEMS placement is safe in small bowel tumor obstruction. However, cSEMS is accompanied with a high rate of migration in comparison to uncovered SEMS.
Background: We analyzed whether co-occurring mutations influence the outcome of systemic therapy in ALK-rearranged non-small-cell lung cancer (NSCLC).
Patients and methods: ALK-rearranged stage IIIB/IV NSCLC patients were analyzed with next-generation sequencing and fluorescence in situ hybridization analyses on a centralized diagnostic platform. Median progression-free survival (PFS) and overall survival (OS) were determined in the total cohort and in treatment-related sub-cohorts. Cox regression analyses were carried out to exclude confounders.
Results: Among 216 patients with ALK-rearranged NSCLC, the frequency of pathogenic TP53 mutations was 23.8%, while other co-occurring mutations were rare events. In ALK/TP53 co-mutated patients, median PFS and OS were significantly lower compared with TP53 wildtype patients [PFS 3.9 months (95% CI: 2.4–5.6) versus 10.3 months (95% CI: 8.6–12.0), P < 0.001; OS 15.0 months (95% CI: 5.0–24.9) versus 50.0 months (95% CI: 22.9–77.1), P = 0.002]. This difference was confirmed in all treatment-related subgroups including chemotherapy only [PFS first-line chemotherapy 2.6 months (95% CI: 1.3–4.1) versus 6.2 months (95% CI: 1.8–10.5), P = 0.021; OS 2.0 months (95% CI: 0.0–4.6) versus 9.0 months (95% CI: 6.1–11.9), P = 0.035], crizotinib plus chemotherapy [PFS crizotinib 5.0 months (95% CI: 2.9–7.2) versus 14.0 months (95% CI: 8.0–20.1), P < 0.001; OS 17.0 months (95% CI: 6.7–27.3) versus not reached, P = 0.049] and crizotinib followed by next-generation ALK-inhibitor [PFS next-generation inhibitor 5.4 months (95% CI: 0.1–10.7) versus 9.9 months (95% CI: 6.4–13.5), P = 0.039; OS 7.0 months versus 50.0 months (95% CI: not reached), P = 0.001).
Conclusions: In ALK-rearranged NSCLC co-occurring TP53 mutations predict an unfavorable outcome of systemic therapy. Our observations encourage future research to understand the underlying molecular mechanisms and to improve treatment outcome of the ALK/TP53 co-mutated subgroup.
Internationale sprachwissenschaftliche Konferenz "Korpuslinguistik Deutsch-Tschechisch kontrastiv" in Sambachshof und Würzburg, 06.-08. Oktober 2009 (Iva Kratochvílová, Norbert Richard Wolf)
"Tschechen und Deutsche im 20. und 21. Jahrhundert. Neue Sichtweisen auf alte Probleme." Deutsch-tschechisches Seminar in Sankelmark, 09.-11. Oktober 2009 (Jarmila Jehličková)
Von der Grenze zum Dazwischen. Ein tschechisch-österreichisches Projekt zur Grenze und der Veränderung ihrer Wahrnehmung in Wien, 9.-11. November 2009 und Brünn 7.-10. Dezember 2009 (Michaela Kropik, Katharina Wessely)
Bericht über den V. Germanisten-Kongress in Sevilla, 16.-18. Dezember 2009 (Fernando Magallanes)
Bericht über die Linguistik-Tage in Freiburg im Breisgau, 02.-04. März 2010 (Martin Lachout)
Sprachliches Wissen zwischen Lexikon und Grammatik. Bericht über die 46. Jahrestagung des Instituts für Deutsche Sprache in Mannheim, 09.-11. März 2010 (Veronika Kotůlková)
"Mittlerin aus Europas Mitte" – 3. MGV-Kongress in Wien, 08.-10. April 2010 (Manfred Glauniger)
"Gedichte und Geschichte – Zur poetischen und politischen Rede in Österreich". Tagung der Franz Werfel-Stipendiaten und –Stipendiatinnen in Wien, 16.–17. April 2010 (Roman Kopřiva)
Binationales Kolloquium zur Problematik der Migrationsformen im 20. und 21. Jahrhundert in Geschichte und Kunst in Ústí nad Labem, 22.-24. März 2010 und Linz 04.-07. Mai 2010 (Jarmila Jehličková)
Ein "hinternationaler" Schriftsteller aus Böhmen: Dritte internationale Johannes-Urzidil-Konferenz in Ústí nad Labem, 05.-08. Mai 2010 (Vera Schneider)
"Wir sind Tschechinnen, wir schreiben Deutsch!" – Öffentliche Gesprächsrunde mit deutschsprachigen Autorinnen in Prag, 13. Mai 2010 (Jenifer Johanna Becker)
"Überkreuzungen. Verhandlungen kultureller, ethnischer, religiöser und geschlechtlicher Identitäten in österreichischer Literatur und Kultur." MALCA-Tagung in Wien, 22.-25. Mai 2010 (Daniela Drobna, Katharina Haderer, Natalie Lamprecht, Friedrich Teutsch, Esther Wratschko)
Due to the increasingly heterogeneous trajectories of aging, gerontology requires theoretical models and empirical methods that can meaningfully, reliably, and precisely describe, explain, and predict causes and effects within the aging process, considering particular contexts and situations. Human behavior occurs in contexts; nevertheless, situational changes are often neglected in context-based behavior research. This article follows the tradition of environmental gerontology research based on Lawton’s Person-Environment-Interaction model (P-E model) and the theoretical developments of recent years. The authors discuss that, despite an explicit time component, current P-E models could be strengthened by focusing on detecting P-E interactions in various everyday situations. Enhancing Lawton’s original formula via a situationally based component not only changes the theoretical perspectives on the interplay between person and environment but also demands new data collection approaches in empirical environmental research. Those approaches are discussed through the example of collecting mobile data with smartphones. Future research should include the situational dimension to investigate the complex nature of person environment interactions.